FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4122511000001103: Skelid 200mg tablets (Sanofi-Synthelabo Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17995701000001115 Skelid 200mg tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65945801000001111 Skelid 200mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely tiludronic acid 200 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Is a Tiludronic acid 200mg tablets false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Is a Tiludronic acid 200mg tablets true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Tiludronate false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Tiludronate disodium false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Tiludronate disodium false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Is a Skelid true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tiludronic acid true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Tiludronate disodium true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has active ingredient Tiludronic acid false Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Has basis of strength substance Tiludronic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Is pack of False Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Skelid 200mg tablets (Sanofi-Synthelabo Ltd) 28 tablet 2 x 14 tablets Has AMP True Skelid 200mg tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start